Cancer and Haematology

Thanks to modern treatments, people with haemophilia live a normal life. But what will decades of medication mean for them as they reach old age? Jovan Antović researches blood clotting and haemophilia, especially in relation to elderly health.

The range of cancer therapies is growing quickly, but it is often hard to know in advance which drug will help a particular patient. Rimma Axelsson uses PET imaging to select patients for effective targeted treatment.

Neuroscientist Ola Hermanson aims to both understand the development of the healthy brain and lay the groundwork for improved treatments for serious diseases. He is also keen to drive technological developments in bioprinting, amongst other areas.

Katalin Dobra researches cancer of the lungs, especially the part played by the protein Syndecan 1. Education is an important aspect of her professorship and she is in charge of the pathology module of the new medical programme.

Lymphoma is a common cancer that exists in many forms. Karin Ekström Smedby is mapping the epidemiology of the disease, from risk factors to survival. She is also researching new biomarkers that can lead to more efficacious treatment.

The oral microbiome not only causes dental diseases, it also impacts on diseases elsewhere in the body. This is the focus of Margaret Sällberg Chen’s research, especially in relation to cancer.

Keith Humphreys develops and uses statistical methods for epidemiological research. He has a special interest in breast cancer risk assessment and in the studying the effectiveness of mammography screening.

Lennart Blomqvist researches cancer imaging, and has among other things helped to develop a method for the measurement of segmental liver function using MRI.

Jan Zedenius is investigating cancer in the thyroid gland. He wants to understand the differences between various forms of the disease and how to detect these differences as early as possible.

While prostate cancer claims many lives, overtreatment is also a significant problem. Martin Eklund develops methods of individualising diagnosis and treatment to reduce fatalities and overtreatment.

Exosomes are tiny particles secreted by cells. They are involved in important processes in the body and may have useful clinical applications, including improved cancer treatments. Susanne Gabrielsson is one of the veterans of this young field of research.

Johan Hartman is developing new diagnostic methods for predicting therapeutic responses and judging relapse risk in cancer. The methods range from patient-derived three-dimensional tumour models to AI-aided risk assessment.

Lars E Eriksson researches earlier detection of lung cancer through the charting of early symptoms and biomarkers. He also researches organisational issues in healthcare as well as stigma and quality of life in patients with chronic infections like HIV.

Sir David Lane discovered the protein p53 at the end of the 1970s. The protein's role is to discover and prevent genetic mutations that can lead to cancer.

The continual division of cells in our bodies is pre-conditional to life; however, the process is a complex and delicate one and subject to serious error.

Sonia Lain is searching for molecules that have the potential to become future cancer therapies. She is searching for substances that are effective against cancer cells but easier on healthy tissue.

Magnus Nilsson conducts research on better treatments against cancer of the oesophagus and stomach. The objective is both to make the treatments more effective, and to make them less invasive.

Stephan Mielke research focuses on exploiting the potential of the patient’s own immune system to fight cancer as well as on improved methods for transplanting blood stem cells.